EU regulator discovers link between heart inflammation and mRNA COVID-19 vaccine



European drug regulators have discovered a possible link between rare heart inflammation and Pfizer and Moderna’s COVID-19 vaccine, and J & J’s coronavirus infection in people with a history of rare blood disorders I advised you to avoid.

The European Medicines Agency (EMA) Safety Commission said Friday that heart disease myocarditis and pericarditis need to be listed as possible side effects of the two mRNA vaccines.

EMA states that such cases occurred primarily within 14 days of vaccination and more frequently in younger adult males after the second dose. This is in line with last month’s findings from US health authorities.

The EMA Committee also recommended that people with a history of capillary leak syndrome (CLS) should not be vaccinated with J & J’s single vaccine. The June Watchdog asked to add CLS as a side effect of AstraZeneca’s shots.

Both AstraZeneca and J & J vaccines use different versions of the cold virus to provide instructions for creating a coronavirus protein that produces an immune response.

Pushkara Aripaka